Home » Topics » Regulatory » Patents

Patents
RSS

Acerta Pharma patents BTK inhibitors

April 27, 2016

F. Hoffmann-La Roche patent divulges CYP11B2 inhibitors

April 26, 2016

Constellation Pharmaceuticals and Genentech jointly develop KDM5A inhibitors

April 26, 2016

Glenmark Pharmaceuticals introduces inhibitors of S-nitrosoglutathione

April 26, 2016

Epigenetics Pharma reports silylated pyrimidine prodrugs

April 26, 2016

Merck & Co. discloses hypoxia-inducible factor prolyl hydroxylase inhibitors

April 26, 2016

Mitobridge and The Salk Institute patent PPARdelta agonists

April 26, 2016

GlaxoSmithKline and New York University describe antiprotozoal agents

April 25, 2016

RespiVert and Topivert Pharma disclose p38 kinase inhibitors

April 25, 2016

H. Lundbeck patents PDE1 inhibitors

April 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...